Stoke Therapeutics STOK Trading at 3009 Key Decision Point 20260520 The OLB OLB Q4 2025 Earnings Beat Revenue 867690700 EPS 012 PlayStation Plus Price Hikes Trigger Widespread Backlash Among Subscribers as Sony Adjusts Membership Costs Bond Bull Market Pauses but Remains Intact Say Analysts